• About
  • Subscribe
  • Advertise
  • Contact
Monday, March 16, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Diabetes and hearing loss: Referral guidance for optometrists

by Dr Mehwish Nisar
February 23, 2026
in CPD - optometry, Diabetic eye disease, Eye disease, Feature, Local, Ophthalmic education, Ophthalmic insights, Report
Reading Time: 12 mins read
A A
Optometrists need to be mindful of hearing
loss as well as visual issues when working
with patients. Image: New Africa/stock.adobe.com.

Optometrists need to be mindful of hearing loss as well as visual issues when working with patients. Image: New Africa/stock.adobe.com.

Share on FacebookShare on Twitter

At the completion of this article, the reader should…

•  Understand the association between diabetes mellitus and hearing loss.

•  Recognise the shared pathophysiological mechanisms affecting the eye and the ear in diabetes.

•  Implement a systematic approach to screening for hearing loss in patients with diabetes.

•  Confidently refer patients with diabetes for audiological assessment when indicated.

Image: Dr Mehwish Nisar.

Dr Mehwish Nisar
MD, PhD
Research Fellow
Centre for Hearing Research (CHEAR)
School of Health and Rehabilitation Sciences
The University of Queensland

Practising optometrists are well aware of diabetes’ effects on the eye, but its impact on hearing often goes unnoticed. Dr Mehwish Nisar highlights the link between diabetes and hearing loss, providing practical guidance on screening and referral. By incorporating these strategies, optometrists can play a vital role in holistic care and improve outcomes for patients with diabetes.

The systemic and ocular changes that occur during the progression of diabetes mellitus are well-known to optometrists. However, the impact of diabetes on the auditory system is a less recognised but equally important consideration.

Compelling evidence indicates that individuals with diabetes are twice as likely to experience hearing loss compared with those without the condition, with the risk increasing further with age and the duration of diabetes.1

This significantly impairs the quality of life and diabetes self-management.

The routine interactions between optometrists and their diabetic patients can offer opportunities to detect early auditory dysfunction, facilitate timely referrals, and advance holistic care.2

Such proactive screening expands the optometrist’s role from eyecare specialist to broader advocate for the patient’s sensory wellbeing, and fosters a more integrated approach to chronic disease management.

The overlooked link: diabetes and sensorineural hearing loss

The evidence base connecting diabetes and sensorineural hearing loss is robust and growing. Multiple epidemiological studies and meta-analyses demonstrate a higher prevalence and accelerated progression of sensorineural hearing loss in individuals with diabetes.1,3

A recent analysis found significantly higher hearing loss rates in Type 2 diabetes patients versus controls (53% vs 25.2%, p < .0001), with 15% unilateral and 29.6% bilateral loss in the diabetic group (both p < .01).3

Sensorineural hearing loss, the most common diabetes-associated hearing loss, involves inner ear or auditory nerve damage with insidious progression.4

The underlying pathophysiological mechanisms mirror those of diabetic retinopathy: microangiopathy impairs cochlear blood supply, neuropathy disrupts auditory nerve transmission, metabolic disturbances harm hair cells, and basement membrane thickening impedes exchange processes, all cumulatively affecting high-frequency hearing and speech comprehension.5,6

Why hearing loss matters in comprehensive diabetes care

Untreated hearing loss profoundly impacts quality of life, causing social isolation, depression, and cognitive decline.7

Within diabetes management, hearing impairment disrupts essential patient-provider communication, compromising diabetes education, self-management, and treatment adherence, and ultimately worsening health outcomes. Additionally, hearing loss independently increases fall risk, compounding existing diabetes-related concerns from peripheral neuropathy.

Early identification and intervention enable healthcare providers to mitigate these risks, enhancing overall patient wellbeing and optimising comprehensive diabetes care outcomes.8

Shared pathophysiology: the eye and the ear

Both the retina and cochlea are highly specialised, metabolically active structures dependent on intricate microvascular networks, rendering them exceptionally vulnerable to diabetic injury.5

Emerging evidence strengthens this connection: studies demonstrate that individuals with proliferative diabetic retinopathy face significantly elevated hearing loss risk compared with those with non-proliferative or absent retinopathy.5,9

This correlation positions advanced retinal disease as a systemic warning signal extending to auditory compromise.4

Table 1 compares the shared pathophysiology and differences between diabetic retinopathy and sensorineural hearing loss.

Table 1. Shared Pathophysiology Between Diabetic Retinopathy and Sensorineural Hearing Loss (3,11)

Guidance for optometrists: integrating hearing awareness

Optometrists are ideally placed to identify at-risk patients for diabetes-related hearing loss. By incorporating simple screening strategies into routine clinical practice, they can facilitate timely referrals.10,11

In-practice screening

The first step in identifying a potential hearing problem is to ask. A few targeted screening questions can be highly effective in flagging patients who may require further investigation (Table 2). These questions should be asked of all patients with diabetes, regardless of age or retinopathy status. A positive response should prompt a recommendation for a formal hearing assessment. In addition to direct questioning, validated screening questionnaires can be a quick and effective way to identify patients who may have a hearing problem.

TABLE 2. Example of screening questions for patients with diabetes.

Referral triggers and pathways

The decision to refer a patient for a hearing assessment should be based on a combination of the patient’s history, clinical findings and risk factors (Table 3). The presence of diabetic retinopathy, particularly PDR, should be considered a major red flag for other microvascular complications and should prompt a strong recommendation for a comprehensive hearing assessment.12

Table 3. Diabetes and hearing loss – optometric referral guidance (5,13,15).

If a patient expresses any concerns about their hearing, it is essential to document these in the patient’s record and to make a formal referral.

The referral can be made to the patient’s general practitioner (GP), who can then coordinate a referral to an audiologist, or directly to an audiology clinic if local pathways permit.

The referral letter should clearly state the patient’s diabetes status, any relevant ocular findings, and the specific auditory concerns raised by the patient.15

Integrating hearing awareness into diabetes-related eyecare does not require optometrists to be audiologists. Instead, it involves adopting a proactive, observational approach to identify potential auditory concerns and facilitate timely referrals to appropriate specialists.

Strengthening interprofessional referrals and collaborative care

Effective diabetes complication management demands collaborative, interprofessional approaches, with optometrists best positioned to initiate crucial hearing care referral pathways.2

Optimal care utilises integrated electronic health records enabling seamless, secure information sharing among optometrists, GPs, endocrinologists, and audiologists, ensuring comprehensive patient profiles across providers.

Optometry practices should develop clear, formal referral protocols with local audiology clinics and GPs through pre-printed referral pads, digital templates, or secure messaging channels that streamline processes.

Multidisciplinary team meetings and informal case discussions significantly enhance coordination for complex diabetic patients.2,4

Practical communication improvements include clear, concise referral letters that explicitly state the patient’s diabetic status, the referral rationale, and relevant ocular findings.

Optometrists should explicitly request feedback from audiologists or GPs on assessment findings, thereby closing the communication loop and enriching their understanding of patients’ systemic health status, and ultimately fostering more comprehensive, coordinated diabetes care across specialties.11,15

Detection and preventive opportunities

Early hearing loss detection in diabetic populations enables timely intervention, potentially slowing progression, improving communication, and enhancing quality
of life.

While standardised screening guidelines remain undeveloped, pragmatic approaches include baseline hearing assessment following diabetes diagnosis, periodic screenings every one to three years, particularly for patients with diabetic retinopathy, poor glycaemic control, or microvascular complications, and prompt assessment when hearing difficulties emerge.

Optometrists can employ opportunistic screening through simple questions to identify patients requiring formal audiological evaluation, a practical approach for busy practices.

Formal audiological assessment by qualified audiologists using pure-tone and speech audiometry remains the diagnostic gold standard.3

Additionally, validated smartphone applications and online hearing screeners provide initial indicative assessments; while non-diagnostic, these tools can motivate professional evaluation, and optometrists can recommend them to concerned patients as preliminary screening steps before formal audiological referral.

Population considerations: focus on at-risk groups

Specific population risks and cultural factors critically inform diabetes and hearing loss management.

  In Australia, Aboriginal and Torres Strait Islander peoples experience significantly elevated Type 2 diabetes rates with earlier onset and severe complications, alongside alarmingly high chronic otitis media rates and childhood-onset hearing loss, exacerbating diabetes-related hearing loss and creating profound auditory challenges.1

Culturally and linguistically diverse immigrant communities also demonstrate higher diabetes prevalence and less utilisation of hearing care services.7,14

Addressing these disparities requires accessible screening programs, culturally relevant educational materials, and robust partnerships with indigenous health services and multicultural community organisations for equitable, effective care delivery.

Looking ahead: integration in diabetes protocols

Future diabetes management requires integrated, patient-centred approaches transcending “siloed specialist care”.

Protocols should incorporate routine holistic sensory screening using validated point-of-care tools, identifying both retinopathy and hearing loss in optometry and general practice settings.

Enhanced interdisciplinary training would strengthen understanding and improve referral processes and collaborative management.

Technological innovations – tele-audiology and AI-powered remote screening – promise expanded accessibility in underserved populations, mirroring successful tele-ophthalmology models.

Additionally, patient empowerment through comprehensive complication education will enhance self-management engagement and screening adherence, optimising long-term visual and auditory health outcomes.

Conclusion

Hearing loss is a significant and often-overlooked complication of diabetes with a substantial impact on an individual’s quality of life.

Optometrists, as primary eyecare providers, are in a unique position to identify patients at risk and facilitate early referral for auditory assessment.

By recognising the shared pathophysiology of the eye and the ear in diabetes, and by integrating simple screening questions and referral practices into their routine care, optometrists can play a vital role in improving the overall health and wellbeing of their patients with diabetes.

The time has come to break the silence on diabetic hearing loss and embrace a more integrated approach to sensory care in diabetes management.

References:

1. Nisar M, Dawes P. Diabetes and hearing loss: A call to action for early detection and prevention. Australian Journal of General Practice 2025;54:747-9.

2. Colagiuri R. The optometrist’s role in the multidisciplinary diabetes team: towards a more holistic approach. Clinical and Experimental Optometry 1999;82(2-3):55-8.

3. Kim CHs, Lauritsen KL, Nguyen SA, Meyer TA, Cumpston EC, Pelic J, et al. Characteristics of Hearing Loss in Type 2 Diabetes Mellitus: A Systematic Review and Meta–Analysis. Otolaryngology–Head and Neck Surgery 2025.

4. Khan MA, Qureshi A, Faisal Z, Fatima K, Farooq M, Ahmed W. Assessing the Correlation between Hearing Loss and Diabetic Retinopathy Severity in Patients at A Tertiary Care Hospital in Pakistan: Correlation Between Hearing Loss and Diabetic Retinopathy Severity in Patients. Pakistan Journal of Health Sciences 2025:176-80.

5. Alizadeh Y, Jalali MM, Sehati A. Association of different severity of diabetic retinopathy and hearing loss in type 2 diabetes mellitus. American Journal of Otolaryngology 2022;43(2):103383.

6. Kurt E, Öztürk F, Günen A, Sadikoglu Y, Sari RA, Yoldas TK, et al. Relationship of retinopathy and hearing loss in type 2 diabetes mellitus. Annals of ophthalmology 2002;34(3):216-22.

7. Strutt PA, Barnier AJ, Savage G, Picard G, Kochan NA, Sachdev P, et al. Hearing loss, cognition, and risk of neurocognitive disorder: evidence from a longitudinal cohort study of older adult Australians. Aging, Neuropsychology, and Cognition 2022;29(1):121-38.

8. Vignesh S, Jaya V, Moses A, Muraleedharan A. Identifying early onset of hearing loss in young adults with diabetes mellitus type 2 using high frequency audiometry. Indian Journal of Otolaryngology and Head & Neck Surgery 2015;67(3):234-7.

9. Shin YU, Park SH, Chung JH, Lee SH, Cho H. Diabetic retinopathy and hearing loss: results from the Fifth Korean National Health and Nutrition Survey. Journal of Clinical Medicine 2021;10(11):2398.

10. Gündoğan M, Gündoğan F, Bayram N, Demircan S, Mutlu C. Evaluation of hearing function in patients with type 2 diabetes mellitus and investigation of its relationship with stages of diabetic retinopathy. Journal of Diabetes & Metabolic Disorders 2025;24(1):143.

11. Al-Abed SA, Hakooz MM, Teimat MH, Aldurgham GA, Alhusban WK, Hjazeen AA, et al. A correlational study of hearing loss and severity of diabetic retinopathy among Jordanian patients. Cureus 2023;15(8).

12. Armstrong D, Stratton RD, Afzal A. Oxidative stress and antioxidant protection : the science of free radical biology and disease. 1st ed. ed. Hoboken, New Jersey: Wiley Blackwell; 2016.

13. Ooley C, Jun W, Le K, Kim A, Rock N, Cardenal M, et al. Correlational study of diabetic retinopathy and hearing loss. Optometry and Vision Science 2017;94(3):339-44.

14. Nickbakht M, Furze C, Nisar M, Waite M, Scarinci N, Newall J, et al. Factors influencing the use of hearing services by diverse ethnic communities in Australia. Ear and hearing 2025:10.1097.

15. DiSogra RM, Beck DL. How chronic illnesses impact hearing, balance, and cognition: a  guide for hearing care professionals. Hearing Review [Internet]. 2025 Mar 12 [cited 2025 Nov 8]; Available from: https://hearingreview.com/hearing-loss/health-wellness/how-chronic-illnesses-impact-hearing-balance-and-cognition-a-guide-for-hearing-care-professionals

Related Posts

Optos ultra-widefield imaging will be on show at events in Western Australia and NSW. Image: Prime Creative Media.

Optos technology on show in upcoming events

by Staff Writer
March 16, 2026

Optos is encouraging eyecare professionals serious about advancing patient care and staying ahead in eye health technology to visit its...

The eye drops can quickly relieve tired, red eyes. Image: LimeSky/stock.adobe.com.

B+L announces launch of Lumify eye drops in Australia

by Staff Writer
March 16, 2026

Bausch + Lomb (B+L) has announced the Australian launch of Lumify redness reliever eye drops in April. The Lumify range...

Dry eye can be exacerbated or even present for the first time after cataract surgery. Image: Pormezz/stock.adobe.com

Dry Eye Society announces Melbourne launch event

by Staff Writer
March 16, 2026

The Dry Eye Society (DES) has announced its official Melbourne launch event, bringing together eye care professionals with a shared interest...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited